» Articles » PMID: 21412765

Cigarette Smoking and Subtypes of Bladder Cancer

Overview
Journal Int J Cancer
Specialty Oncology
Date 2011 Mar 18
PMID 21412765
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

There is little information regarding associations between suspected bladder cancer risk factors and tumor subtypes at diagnosis. Some, but not all, studies have found that bladder cancer among smokers is often more invasive than it is among nonsmokers. This population-based case-control study was conducted in Los Angeles, California, involving 1,586 bladder cancer patients and their individually matched controls. Logistic regression was used to conduct separate analyses according to tumor subtypes defined by stage and grade. Cigarette smoking increased risk of both superficial and invasive bladder cancer, but the more advanced the stage, the stronger the effect. The odds ratios associated with regular smokers were 2.2 (95% confidence intervals, 1.8-2.8), 2.7 (2.1-3.6) and 3.7 (2.5-5.5) for low-grade superficial, high-grade superficial and invasive tumors respectively. This pattern was consistently observed regardless of the smoking exposure index under examination. Women had higher risk of invasive bladder cancer than men even they smoked comparable amount of cigarettes as men. There was no gender difference in the association between smoking and risk of low-grade superficial bladder cancer. The heterogeneous effect of cigarette smoking was attenuated among heavy users of NSAIDs. Our results indicate that cigarette smoking was more strongly associated with increased risk of invasive bladder cancer than with low-grade superficial bladder cancer.

Citing Articles

Clinical and Pathological Characteristics of Bladder Cancer in Patients Aged 18-45 Undergoing Transurethral Resection of Bladder Tumor.

Croitor A, Dema V, Latcu S, Bardan R, Novacescu D, Barbos V Biomedicines. 2024; 12(11).

PMID: 39595014 PMC: 11591727. DOI: 10.3390/biomedicines12112449.


Passive smoking and risk of pancreatic cancer: an updated systematic review and meta-analysis.

Wang X, Wang Z, Wang X PeerJ. 2024; 12:e18017.

PMID: 39399427 PMC: 11468807. DOI: 10.7717/peerj.18017.


Effect of smoking on the recurrence and progression of non-muscle-invasive bladder cancer.

Chen C, Fan G, Li P, Yang E, Jing S, Shi Y Clin Transl Oncol. 2024; .

PMID: 39266874 DOI: 10.1007/s12094-024-03694-z.


Deep learning identifies histopathologic changes in bladder cancers associated with smoke exposure status.

Eminaga O, Lau H, Shkolyar E, Wardelmann E, Abbas M PLoS One. 2024; 19(7):e0305135.

PMID: 39083547 PMC: 11290674. DOI: 10.1371/journal.pone.0305135.


Association between Smoking and Overall and Specific Mortality in Patients with Bladder Cancer: A Population-based Study.

Ho C, Tseng W, Huang S, Liu C, Wu Y, Chiu A Bladder Cancer. 2024; 8(2):129-138.

PMID: 38993361 PMC: 11181781. DOI: 10.3233/BLC-211583.


References
1.
Epstein J, Amin M, Reuter V, Mostofi F . The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998; 22(12):1435-48. DOI: 10.1097/00000478-199812000-00001. View

2.
Hinotsu S, Akaza H, Miki T, Fujimoto H, Shinohara N, Kikuchi E . Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association. Int J Urol. 2008; 16(1):64-9. DOI: 10.1111/j.1442-2042.2008.02194.x. View

3.
Egan K, Lawson J, Fries S, Koller B, Rader D, Smyth E . COX-2-derived prostacyclin confers atheroprotection on female mice. Science. 2004; 306(5703):1954-7. DOI: 10.1126/science.1103333. View

4.
Pruthi R, Derksen E, Gaston K, Wallen E . Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer. Urology. 2004; 64(4):637-42. DOI: 10.1016/j.urology.2004.04.047. View

5.
Knowles M . Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?. Carcinogenesis. 2005; 27(3):361-73. DOI: 10.1093/carcin/bgi310. View